Invasive Candidiasis During Granulocytopenia
Candidiasis remains the most frequently encountered fungal infection in granulocytopenic patients (Horn et al. 1985; Crislip and Edwards 1989). Its increasing frequency has been documented from several institutions and seems highest among patients with acute leukemia. With the advent of newer forms of anticancer therapy, disseminated candidiasis is now more frequently recognized in patients with chronic lymphocytic leukemia receiving fludarabine phosphate and in patients with various malignancies treated with high doses of cytotoxic chemotherapy with autologous bone marrow transplantation.
KeywordsChronic Lymphocytic Leukemia Candida Species Invasive Candidiasis Antifungal Prophylaxis Systemic Candidiasis
Unable to display preview. Download preview PDF.
- Crislip MA, Edwards JE (1989) Candidiasis. Infect Dis Clin North Am 1: 103–133Google Scholar
- Lecciones J, Witebsky F, Marshall D, Gress J, Pizzo P, Walsh TJ (1989) Catheter-associated fungemia in cancer patients: characteristics and clinical outcome. In: Program and abstracts of the 29th interscience conference on antimicrobial agents and chemotherapy, American Society for Microbiology 112 (abstr 68)Google Scholar
- Armstrong D (1989) Problems in the treatment of opportunistic fungal infections. In: Holmberg K, Meyer RD (eds) Armstrong D, pp 149–158 This review analyzes the problems in the diagnosis and treatment of serious mycoses in the immunocompromised host imcluding candidiasis, aspergillosis, mucormycosis, cryptococcosis, the endemic mycoses, and the newly emerging pathogens.Google Scholar
- Bodey GP, Fainstein V (1985) Systemic candidiasis. In: Bodey GP, Fainstein V (eds) Bodey GP, Fainstein V, pp 135–168 Summary article on the frequency of, predisposing factors for, clinical signs and symptoms and management of systemic candidiasis.Google Scholar
- Goodrich JM, Reed EC, Mori M, Fisher LD, Skerrett S, Dandliker PS, Klis B, Counts GW, Meyers JD (1991) Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis 164:731–740 A review of risk factors for invasive candidiasis among 1506 bone marrow transplant patients at the Fred Hutchinson Cancer Research Center. Tissue involvement was associated with a 90% mortality with or without fungemia. Risk factors for infection were increased age, graft-versus-host disease, and donor mismatch.PubMedCrossRefGoogle Scholar
- Pizzo PA (1988) Diagnosis and management of infectious disease problems in the child with malignant disease. In: Rubin RH, Young LS (eds) Pizzo PA, pp 439–464 This chapter discusses the appropriate approach for the management of febrile and granulocytopenic patients, including diagnosis and antibiotic treatment.Google Scholar
- Schimpff SC, Klastersky J, Gaya H (eds) (1986) Therapy of immunocompromised hosts (symposium). Am J Med 80:1–119 A broad-based series covering basic and clinical concerns in therapy with emphasis on granulocytopenic patients and current controversies such as combination versus monotherapy.Google Scholar
- Wade JC, Schimpff SC (1985) Epidemiology and prevention of Candida infection. In: Bodey GP, Fainstein V (eds) Wade JC, Schimpff SC, pp 111 – 133 This chapter discusses the various aspects of the pathogenesis, mechanisms of infection, protal of invasion, and prevention of candidal infections.Google Scholar
- Walsh TJ, Pizzo PA (1988) Treatment of systemic fungal infections: recent progress and current problems. Eur J Clin Microbiol 7:460–475 This review summarizes the current problems in diagnosing fungal infections and the emergence of newer fungi as serious pathogens and discusses antifungal chemotherapy with special emphasis on specific therapy of the various mycoses.CrossRefGoogle Scholar
- Zinner SH, Klastersky J (1985) Infectious considerations in cancer. In: Calabresi P, Schein PS, Rosenberg SA (eds) Medical oncology: basic principles and clinical management of cancer. Macmillan, New York, pp 1327–1357Google Scholar